of cancer or neurogenetic tumor disorders. There was no history of immunosuppressive disorders, use of immunosuppressive medications, or unusual infections. There was no history of recent travel. The patient's white blood cell count was within normal limits.
Examination. On neurological examination, the patient was found to have numbness along the posterior aspect of the right knee and calf and the bottom of the right foot. Proprioception and knee reflexes were normal, but the patient's right ankle reflex was markedly decreased. Weakness of the right gastrocnemius muscle (Grade 2/5) and the right anterior tibial muscle and the long extensor muscle of the great toe (Grade 4/5) was evident. Edema of the right leg was visually noticeable. General physical examination did not reveal signs of cardiopulmonary, hepatorenal, or splenic abnormalities, and there was no evidence of systemic lymphadenopathy. Cutaneous examination did not show the stigmata of neurofibromatosis.
An electromyogram obtained with nerve conduction studies indicated a neuropathic process involving the right posterior tibial nerve more than the common peroneal nerve with ongoing axonal loss. The lesion was thought to be distal to the nerve root and was attributed to a right-sided sciatic nerve lesion. Magnetic resonance imaging revealed a fusiform tumor that involved the sciatic nerve, beginning 10 cm below the lesser trochanter of the femur and extending 6 cm below the popliteal fossa into the posterior tibial nerve ( Figs. 1 and 2 ). The tumor displayed an intermediate signal on proton-density MR images and a hyperintense signal on T 2 -weighted images. It enhanced slightly and heterogeneously after administration of contrast materials, with a small amount of peripheral enhancement. There was no evidence of direct extension into the surrounding muscles, tendons, or fat. A preoperative radiological diagnosis of schwannoma was made.
Operation. The patient's posterior right leg was prepared in a sterile fashion, and an incision was made from the midline of the thigh into the crease of the popliteal fossa. A neoplastic growth was found encasing the sciatic and posterior tibial nerves circumferentially, with relative sparing of the common peroneal nerve. A frozen section obtained intraoperatively contained an atypical lymphocytic infiltrate, which was consistent with the findings of a malignant lymphoma. Resection of the sheaths of tumor encasing the nerves revealed, by gross examination, that tumor tissue had likely infiltrated the entire nerve substance.
Pathological Findings. The neoplasm was composed of mitotically active, intermediate-sized lymphocytes with a prominent nuclear membrane, coarsely clumped chromatin, generally prominent nucleoli, and a scant-to-moderate cytoplasm (Fig. 3) . Cytoplasmic vacuolation was not prominent. In areas, occasional macrophages were intermixed with neoplastic cells, yielding a starry sky-like appearance on low magnification. The majority of neoplastic cells were immunopositive for CD20, immunoglobulin M heavy chain, and light chain, whereas the intermixed, reactive, small lymphocytes were positive for FIG. 1. Coronal T 1 -weighted MR image, extending from the proximal femur to the junction of the tibia, illustrating a fusiform enlargement of the right sciatic nerve. The tumor (arrowheads) originates 10 cm below the lesser trochanter and extends 6 cm below the tibial plateaus where the tibial nerve appears normal in caliber and exhibits normal signal characteristics. Tumor extension into adjoining tissues is not seen. On short-tau inversion recovery and T 2 -weighted fat-saturated sequences (not shown) we found evidence of subacute denervation changes in the proximal gastrocnemius and popliteal muscles. the T-cell marker CD3. The final diagnosis was highgrade Burkittlike B-cell lymphoma. 9 Postoperative Course. Staging studies, instituted immediately after surgery, did not reveal evidence for lymphomatous involvement of other organs or the CNS. These studies included computerized tomography scanning of the chest, abdomen, and pelvis, with and without addition of a contrast agent; bone marrow biopsy; lumbar puncture; and MR imaging of the spinal cord. The results of tests for human immunodeficiency virus were negative. Nevertheless, to purge potential lymphoma cells, the patient underwent systemic chemotherapy, including four cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone, over the following 4 months. At the conclusion of this chemotherapy regimen, radiotherapy to the sciatic and posterior tibial nerves was planned; however, the patient developed a palsy of the right facial nerve. At this juncture, repeated analysis of cerebrospinal fluid revealed 503 white blood cells/ml, 97% of which were atypical lymphocytes consistent with lymphoma. Magnetic resonance imaging of the brain and spinal cord (with and without administration of gadolinium) did not reveal evidence of parenchymal involvement of the CNS by tumor. Repeated staging studies, including a biopsy of the patient's bone marrow, again proved negative for systemic lymphomatous involvement. Intrathecal chemotherapy, consisting of cytosine arabinoside and oral dexamethasone, as well as craniospinal radiation led to the elimination of white blood cells in the patient's spinal fluid; this treatment was associated with improvement in the patient's Bell's palsy. Although additional staging studies continued to demonstrate no systemic involvement, the apparently rapid progression of tumor from the PNS into the CNS prompted plans for further treatment that included myelosuppressive doses of cyclophosphamide, followed by an allogenic bone marrow transplant protocol. On Day 2 of this chemotherapy regimen, the patient experienced the sudden onset of respiratory failure and could not be revived, despite application of cardiopulmonary resuscitation.
Postmortem Examination. Malignant lymphoma was identified in association with peripheral nerves, including the right sciatic, common peroneal, and posterior tibial nerves; the right and left proximal femoral nerves; and multiple cervical, thoracic, and lumbar spinal nerve roots and associated nerve root ganglia. Based on immunocytochemical and histological studies, this neoplasm was identical to that identified at the surgical biopsy. Diffuse invasion of lymphoma cells was observed microscopically in the epineurium between nerve fascicles (Fig. 4) . Interestingly, the intracranial portions of the facial and acoustic nerves were not involved by the lymphoma. In addition, there was no microscopic evidence of lymphomatous involvement of the subarachnoid space, arachnoid, or dura of the spinal cord or brain, although rare atypical lymphocytes were present, admixed with small benign-appearing lymphocytes in connective tissue adjacent to the sella turcica. There was no microscopic evidence of involvement of bone marrow, lymph nodes, or systemic organs by lymphoma cells.
Discussion

Description of the Disease
Malignant NHLs are defined as malignant proliferations of either B or T lymphocytes. 18 The provisional diagnostic entity "high-grade B-cell lymphoma, Burkittlike," was proposed by the international lymphoma study group as part of the revised European-American classification of lymphoid neoplasms (known as the REAL classification). 9 This category was proposed to accommodate a group of lymphomas with histological features, including cell size and nuclear structures, that are intermediate between large-cell lymphoma (centroblastic or immunoblastic) and Burkitt's lymphoma, have a high proliferation rate, and appear with or without a starry-sky pattern. Based on immunophenotypical studies, the neoplastic cells demonstrate positivity for B-cell antigens and negativity for CD5, CD10, and T-cell antigens. These aggressive and often fatal neoplasms are most common in adults with or without a history of immunosuppression. Usually they present within lymph nodes rather than in extranodal sites. A recent publication of the results of two studies in which the authors sought to validate the REAL classification found that high-grade Burkittlike B-cell lymphoma was the 10th most common diagnosis, reported in 30% of 1779 cases of NHL. 7 Burkittlike lymphoma was recently shown to comprise 18.4% of cases in a series of 103 lymphomas in patients with acquired immunodeficiency syndrome. 2 When lymphomatous infiltration of spinal nerve roots, dorsal root ganglia, and peripheral nerves occurs, it is usually a consequence of hematogenous spread from systemic NHL or the result of invasion from adjacent structures. Diaz-Arrastia, et al., 4 reviewed the manifestation of neurolymphomatosis in 39 patients and defined it as a clinical disorder with signs of peripheral neuropathy that is confirmed by histopathological evidence of lymphomatous infiltration of the nerves. Typically, patients present with a history of a subacute course lasting for weeks and less commonly with an acute or rapid onset. Pain is a very common symptom in patients with lymphomatous infiltration of the peripheral nerves. Two of the 39 cases reviewed by Diaz-Arrastia, et al., initially were thought to have presented with malignant lymphoma of the sciatic nerve; 14, 15 however, no autopsies were performed and histopathological evidence of infiltration of nerves by malignant cells to confirm this clinical diagnosis was not obtained. Purohit and associates 15 described a patient who initially presented with clinical evidence of sciatic nerve lymphoma, which was followed by development of enlarged axillary lymph nodes 3 years later. Subsequent biopsy and histological analysis demonstrated the presence of systemic NHL, but no evidence of peripheral nerve tumor. In a case reported by Eusebi and colleagues, 5 neoplastic involvement in the subarachnoid space and the retroperitoneum was found at autopsy, but there was no report of infiltration of peripheral nerves. A patient described by Roncaroli, et al., 18 died 50 months after diagnosis, presumably due to spreading from the initial sciatic nerve lymphoma to the CNS; however, a postmortem examination was not performed to confirm this. Therefore, the hypothesis that a solitary lymphoma in a peripheral nerve can represent the initial presentation of a more severe and diffuse lymphomatous involvement of the CNS, PNS, or other organ systems has yet to be supported by pathological data in currently published literature.
The patient in the present case exhibited clinical characteristics that were similar to those of patients described in previous reports of primary lymphoma of the sciatic nerve. In all instances, the initial presentation consisted of progressive and painful paresis of muscles innervated by the sciatic nerve, without evidence of systemic or CNS involvement by tumor cells. A variety of treatments were instituted, but none seems to have affected the final, unfortunately fatal, outcome. The grade of the lymphoma also did not affect the outcome. For instance, the life expectancy of the patient presented in the current report and those presented by Purohit and associates, 15 Eusebi and colleagues, 5 and Roncaroli, et al., 16 ranged from 16 to 50 months after detection of the sciatic nerve lesion. Although Pillay, et al., 14 and Kanamori and coworkers 12 did find regression of tumor in two patients treated with a combination of local radiotherapy and chemotherapy, the reported duration of follow up was for a period of only 12 or 30 months. The case reported by Kanamori and coworkers consisted of a diffuse, T-cell lymphoblastic tumor, whose natural history and biological behavior is likely to be very different from the B-cell lymphomas that constitute the subject matter of the present study.
Speculation on Pathogenesis
Failure to control lymphomatous involvement of the nervous system provides an impetus for speculating on its pathogenesis and on different approaches toward treatment. The pathogenesis of tumor infiltrates in a solitary lymphoma of a peripheral nerve remains a mystery. Although a hematogenous route may be responsible for lymphomatous infiltration of the peripheral nerves, 4 in the present case there seemed to be complete absence of tumor at sites outside the PNS, at least at initial presentation. Lymphoma cells were found within the CNS 4 months after surgical treatment; however, these were rapidly purged through intrathecal chemotherapy. Postmortem studies revealed extensive infiltration of multiple nerves within the PNS, but a remarkable absence of tumor in other organs and tissues, including the CNS. Several hypotheses concerning the pathogenesis of this particular tumor can be made.
Original Spread of Lymphoma Cells to Multiple Nerves and to the CNS Through a Hematogenous Route.
Initial presentation through sciatic nerve disease would be fortuitous and, with time, other nerves would become infiltrated by tumor. Systemic and intrathecal chemotherapeutic interventions lead to purging of the tumor from all sites except the PNS. The presence of a blood-nerve barrier that limits the diffusion of chemotherapy agents could explain the failure of systemic chemotherapy regimens in eliminating tumor cells from the peripheral nerves of our patient and in other reported patients.
Specific Targeting of Peripheral Nerves by Lymphoma
Cells Generated Elsewhere in the Body. The ability of immunoglobulin-producing B cells to course within nerves and react against nerve components is known to occur in polyneuropathies, and one might speculate that a similar phenomenon occurred in the present case. This would explain the predilection for the extensive lymphomatous involvement of nerves, which was observed at postmortem analysis.
Extranodal Generation of Lymphoma Within the Sciatic Nerve With Secondary Spread to Other Sites Within the PNS and CNS.
We tend to favor this last mechanism of pathogenesis for the currently reported case because extensive imaging studies and postmortem analyses failed to demonstrate involvement of systemic organs. Involvement of the CNS occurred late in the course of the disease, suggesting that the CNS represented a secondary site. We postulate that the original lymphoma could have arisen from B cells that normally course through or reside in the sciatic nerve. This site provided the reservoir for dissemination of tumor cells along peripheral nerve tracts into the CNS. It is possible that additional spread into systemic organs may have occurred, but that the instituted chemotherapy regimens resulted in successful purging of tumor from all sites except the PNS.
The diffuse involvement of spinal cord nerve roots raises the possibility of a neurogenic basis for the respiratory failure that led to our patient's fatal outcome. Therefore, the high mortality rate that is associated with the diagnosis of a B-cell lymphoma of a sciatic nerve suggests that aggressive and prophylactic treatment of the CNS may be required, even in the absence of initial lymphomatous involvement. Furthermore, aggressive and early radiotherapeutic and/or surgical management of the involved limb, including amputation, should be considered to eliminate a site that can provide neoplastic cells to the remainder of the body. Finally, initial administration of aggressive myelosuppressive chemotherapies may also have to be considered.
Conclusions
A solitary primary malignant peripheral nerve lymphoma can progress to a lymphomatosis involving the subarachnoid spaces (potentially treatable by intrathecal chemotherapy) and to diffuse neurolymphomatosis of multiple peripheral nerves, whose treatment remains elusive, as illustrated in the reported case. As previously discussed, aggressive myelosuppressive chemotherapeutic regimens and extensive surgical or radiotherapeutic measures should be considered when a patient presents with a solitary high-grade B-cell lymphoma of a peripheral nerve because it may be the harbinger of a more disseminated tumor within the PNS and CNS.
